Significant racial and ethnic disparities exist in the management of postdural puncture headache with an epidural blood patch among obstetric patients, according to a New York State study published in JAMA Network Open.
Significant racial and ethnic disparities exist in the management of postdural puncture headache with an epidural blood patch among obstetric patients, according to a New York State study published in JAMA Network Open.1
Compared to White patients, Hispanic, Black and patients of other race and ethnicity were significantly less likely to be treated with an epidural blood patch (EBP), and the timing of the EBP after hospital admission was significantly longer. Both the lack of an EBP and delayed treatment may be linked to long-term adverse effects.
“Although we were aware of the well-documented racial and ethnic disparities in maternal health outcomes, there has been limited research on disparities specifically related to obstetric anesthesia care,” said principal investigator Allison Lee, an associate professor of anesthesiology at Columbia University Irving Medical Center in New York City.
In contrast to non-Hispanic White women, minority women have lower labor epidural rates—despite it being the most effective modality for pain relief—according to Lee, along with higher rates of general anesthesia for cesarean deliveries, which is associated with greater risks and complications for the mother.
“Worse management of pain after cesarean delivery also occurs in minority women,” Lee told Contemporary OB/GYN®.
Due to the importance of effective management of postdural puncture headache and growing evidence of complications if untreated, “we hypothesized that similar patterns of inferior management for this type of headache in minority women would be observed,” Lee said.
The cross-sectional study used New York state hospital discharge records from January 1998 to December 2016. Of the 8921 mothers, aged 15 to 49 (mean age 30), with a postdural puncture headache after neuraxial analgesia or anesthesia for childbirth, 55.6% were White, 14.6% Hispanic, 11.5% Black and 15.2% other race and ethnicity.
Of the cohort, 47.0% were managed with an EBP: 53.4% of White patients vs. 41.7% of Hispanic patients, 35.7% Black patients and 35.2% of patients of another race and ethnicity.
In addition, timing of EBP was a median 2 days after hospital admission for White patients compared to 3 days for Hispanic patients, Black patients and patients of another race and ethnicity (P < 0.001).
“Our hypothesis was proven,” Lee said. “However, we were encouraged that after adjusting for patient and hospital characteristics, there was no difference in the EBP rate among Hispanic patients compared to White patients. But the EBP rate was 20% lower for Black patients and 15% lower for patients of other races and ethnicities.”
Lee noted that anesthesia providers must systematically assess for headache postpartum and intervene quickly. Similarly, other peripartum care providers, including obs and nurses, should be trained for the signs and symptoms of postdural puncture headache and promptly communicate any concerns to the anesthesia providers.
“We encourage all institutions to provide training in implicit bias to clinicians; to review their anesthesia-related outcomes based on race and ethnicity, including perhaps implementing ‘disparities dashboards’; and to provide high-quality information in patients’ preferred language,” said Lee, an officer of diversity, equity and inclusion for the Department of Anesthesiology at Columbia University Irving Medical Center.
Researchers should also evaluate interventions that address disparities, to determine the most effective solutions.
“To better understand these issues, we need more anesthesia-related outcomes collected on a national level to better quantify disparities and initiate corrective measures,” Lee said.
Reference
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Improved maternal cardiac arrest management reported from Obstetric Life Support training
November 19th 2024A study found that Obstetric Life Support education significantly improves health care providers' readiness and outcomes in maternal cardiac arrest management, advocating for broader implementation.
Read More